ImmuPharma (LON:IMM) Shares Cross Below 200 Day Moving Average – Here’s What Happened

Shares of ImmuPharma plc (LON:IMM) crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 7.34 and traded as low as GBX 4.41. ImmuPharma shares last traded at GBX 4.50, with a volume of 3,644,997 shares traded.

ImmuPharma Trading Down 0.7%

The stock’s 50-day simple moving average is GBX 5.95 and its 200-day simple moving average is GBX 7.34. The firm has a market capitalization of £28.08 million, a P/E ratio of -5.06 and a beta of 3.18.

ImmuPharma Company Profile

ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.